SRPT Sarepta Therapeutics Inc

held by 1 manager in Q2 2020

Manager	% of their portfolio	Held	Activity	Value	Shares
Stanley Druckenmiller Duquesne Family Office	0.83%	3 mo	NEW	$27M	169,350

Search